During the past decade, Southeastern Medical Oncology Center-Wilson conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 29 clinical trials were completed, i.e. on average, 120.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 23 clinical trials were completed. i.e. 575% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southeastern Medical Oncology Center-Wilson" #1 sponsor was "SWOG Cancer Research Network" with 21 trials, followed by "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored, "Aileron Therapeutics, Inc." with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southeastern Medical Oncology Center-Wilson" #1 collaborator was "National Cancer Institute (NCI)" with 33 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Halozyme Therapeutics" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Southeastern Medical Oncology Center-Wilson" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Breast Cancer" (5 trials), "Colorectal Cancer" (3 trials) and "Fatigue" (2 trials). Many other conditions were trialed in "Southeastern Medical Oncology Center-Wilson" in a lesser frequency.

Most popular intervention types in "Southeastern Medical Oncology Center-Wilson" are "Drug" (36 trials), "Other" (26 trials), "Biological" (8 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Placebo" (6 trials), "placebo" (6 trials), "Docetaxel" (4 trials) and "Dexamethasone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Southeastern Medical Oncology Center-Wilson" are 37 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Southeastern Medical Oncology Center-Wilson". undefined are not yet recruiting, 2 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Southeastern Medical Oncology Center-Wilson, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Southeastern Medical Oncology Center-Wilson, 6 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".